Santé
AsiDNA™
A new category of drugs to tackle DNA damage
Partnership Carnot Curie Cancer Institute - ONXEO Entreprise
Presentation
Video
Fermer
AsiDNA™ harnesses strong innovation potential for patients suffering from different types of cancer. So how does it work? AsiDNA™ disrupts and depletes the ability of tumour cells to repair their DNA by diverting them from their target as soon as damage is detected.
